Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Achilles Allograft With or Without InternalBrace for ACL Revision Surgery (ACL-AlloRev)

4 maggio 2026 aggiornato da: Medical University of Graz

Achilles Tendon Allografts With and Without InternalBrace Augmentation for Anterior Cruciate Ligament Revision Surgery: A Randomized Controlled Pilot Trial

This study evaluated outcomes after revision anterior cruciate ligament reconstruction using Achilles tendon allografts with a calcaneal bone block, with or without additional InternalBrace augmentation. Revision ACL reconstruction is often more complex than primary ACL reconstruction because previous surgery may leave widened bone tunnels or bone defects. Achilles tendon allografts with attached bone blocks may help address these defects and allow reconstruction in a single surgical procedure.

Participants with MRI-confirmed ACL graft re-tear and clinical knee instability were randomized to undergo revision ACL reconstruction either with InternalBrace augmentation or without InternalBrace augmentation. Clinical outcomes, patient-reported knee function, health-related quality of life, and MRI findings were assessed during 13 months of follow-up. The study was designed as a prospective randomized controlled pilot trial to compare whether additional InternalBrace augmentation improved functional, radiographic, or quality-of-life outcomes after revision ACL surgery.

Panoramica dello studio

Descrizione dettagliata

Anterior cruciate ligament revision surgery remains challenging and may have less predictable outcomes than primary ACL reconstruction. In revision cases, prior bone tunnels and bone defects can complicate graft fixation. Achilles tendon allografts with calcaneal bone blocks provide a reliable graft configuration and may help fill pre-existing bone defects during a one-stage revision procedure. InternalBrace augmentation is intended to provide additional support to the reconstructed ligament during the healing period, but clinical evidence for its use with allograft ACL revision surgery is limited.

This prospective, randomized controlled pilot study enrolled patients from February 2017 to September 2020 at the Medical University of Graz. Eligible participants had MRI-confirmed re-tear of the ACL graft and clinical and patient-reported knee instability. Patients with advanced associated lesions requiring reconstruction or prolonged restricted weight bearing, signs of infection, advanced osteoarthritis, or neuromuscular disease were excluded. For all included participants, the procedure was the first revision surgery on the affected knee. The study was approved by the Ethics Committee of the Medical University of Graz, and written informed consent was obtained before participation.

All participants underwent revision ACL reconstruction using an Achilles tendon allograft with a calcaneal bone block. Participants were randomized in a 1:1 ratio to receive either additional InternalBrace augmentation or no InternalBrace augmentation. The InternalBrace group received a non-resorbable polyethylene FiberTape fixed separately and independently from the ACL graft. Apart from the additional InternalBrace fixation in one group, the surgical technique and postoperative rehabilitation protocol were the same for all participants.

Clinical and patient-reported outcomes were assessed preoperatively and at 6 weeks, 12 weeks, 6 months, and 13 months after surgery. Outcome measures included the International Knee Documentation Committee score, Lysholm Knee Questionnaire, Tegner Activity Scale, Knee Injury and Osteoarthritis Outcome Score, and Short Form-36. MRI scans were performed before surgery and 13 months after surgery to assess graft appearance, graft tightness, graft signal, ligament signs at the femoral and tibial tunnel insertions, and tunnel size.

The final analyzed study population included 30 participants, with 16 participants in the InternalBrace group and 14 participants in the non-InternalBrace group. Overall, clinical and patient-reported outcomes improved during follow-up. At the final 13-month follow-up, there were no clinically relevant differences between the InternalBrace and non-InternalBrace groups. Postoperative MRI showed elongated or insufficient ACL allografts in 15 of 30 participants, without significant differences between groups. The study concluded that ACL revision surgery using Achilles tendon allografts with bone blocks resulted in improved clinical outcomes at 13 months, but additional InternalBrace augmentation did not improve objective or subjective outcomes in this pilot trial.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

32

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Styria
      • Graz, Styria, Austria, 8036
        • Medical University of Graz

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • MRI-confirmed re-tear of the anterior cruciate ligament.
  • Clinical knee instability.
  • Patient-reported knee instability.
  • Planned first revision anterior cruciate ligament reconstruction of the affected knee.
  • Ability to undergo the standardized postoperative rehabilitation protocol.
  • Written informed consent for study participation and use of study data.

Exclusion Criteria:

  • Advanced associated knee lesions, such as pronounced meniscal tears or cartilage defects, requiring reconstruction or prolonged reduced weight bearing.
  • Signs of infection.
  • Advanced-stage osteoarthritis.
  • Neuromuscular disease.
  • Previous revision surgery on the affected knee.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: InternalBrace Augmentation
Participants underwent revision anterior cruciate ligament reconstruction using an Achilles tendon allograft with calcaneal bone block and additional InternalBrace augmentation. The InternalBrace consisted of non-resorbable polyethylene FiberTape fixed separately and independently from the ACL allograft.
Revision anterior cruciate ligament reconstruction was performed using an Achilles tendon allograft with calcaneal bone block. In this group, a non-resorbable polyethylene FiberTape InternalBrace was additionally fixed separately and independently from the ACL allograft to support the graft during healing.
Altri nomi:
  • Revision ACL Reconstruction With InternalBrace
  • ACL Revision Surgery With InternalBrace Augmentation
  • Achilles Tendon Allograft ACL Revision With Suture Tape Augmentation
Comparatore attivo: No InternalBrace Augmentation
Participants underwent revision anterior cruciate ligament reconstruction using an Achilles tendon allograft with calcaneal bone block without additional InternalBrace augmentation. Apart from the InternalBrace augmentation, the surgical technique and postoperative rehabilitation protocol were the same as in the InternalBrace group.
Revision anterior cruciate ligament reconstruction was performed using an Achilles tendon allograft with calcaneal bone block. No additional InternalBrace or suture tape augmentation was used. Apart from the absence of InternalBrace augmentation, the surgical technique and postoperative rehabilitation protocol were the same as in the InternalBrace augmentation group.
Altri nomi:
  • Revision ACL Reconstruction Without InternalBrace
  • ACL Revision Surgery Without InternalBrace Augmentation
  • Achilles Tendon Allograft ACL Revision Without Suture Tape Augmentation

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
International Knee Documentation Committee Score
Lasso di tempo: Preoperative baseline to 13 months after surgery
The International Knee Documentation Committee score was used to assess patient-reported knee symptoms, function, and sports activity after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better knee function.
Preoperative baseline to 13 months after surgery

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Lysholm Knee Questionnaire Score
Lasso di tempo: Preoperative baseline to 13 months after surgery
The Lysholm Knee Questionnaire was used to assess knee symptoms and functional limitations after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better knee function.
Preoperative baseline to 13 months after surgery
Tegner Activity Scale Score
Lasso di tempo: Preoperative baseline to 13 months after surgery
The Tegner Activity Scale was used to assess participant activity level after revision anterior cruciate ligament reconstruction. Scores range from 0 to 10, with higher scores indicating a higher activity level.
Preoperative baseline to 13 months after surgery
Knee Injury and Osteoarthritis Outcome Score
Lasso di tempo: Preoperative baseline to 13 months after surgery
The Knee Injury and Osteoarthritis Outcome Score was used to assess knee-related pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life. Subscale scores range from 0 to 100, with higher scores indicating better outcomes.
Preoperative baseline to 13 months after surgery
MRI Assessment of ACL Allograft Tightness
Lasso di tempo: 13 months after surgery
Postoperative magnetic resonance imaging was used to assess anterior cruciate ligament allograft tightness. Grafts were categorized as tight, elongated, or insufficient.
13 months after surgery
MRI Assessment of Femoral and Tibial Tunnel Size
Lasso di tempo: 13 months after surgery
Postoperative magnetic resonance imaging was used to measure femoral and tibial tunnel size after revision anterior cruciate ligament reconstruction. Tunnel size was measured in millimeters.
13 months after surgery
Short Form-36 Physical Component Summary Score
Lasso di tempo: Preoperative baseline to 13 months after surgery
The Short Form-36 Physical Component Summary score was used to assess physical health-related quality of life after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better physical health-related quality of life.
Preoperative baseline to 13 months after surgery
Short Form-36 Mental Component Summary Score
Lasso di tempo: Preoperative baseline to 13 months after surgery
The Short Form-36 Mental Component Summary score was used to assess mental health-related quality of life after revision anterior cruciate ligament reconstruction. Scores range from 0 to 100, with higher scores indicating better mental health-related quality of life.
Preoperative baseline to 13 months after surgery

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Paul Ruckenstuhl, MD, Department of Orthopaedics and Trauma, Medical University of Graz

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 febbraio 2017

Completamento primario (Effettivo)

30 settembre 2021

Completamento dello studio (Effettivo)

30 settembre 2021

Date di iscrizione allo studio

Primo inviato

27 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

27 aprile 2026

Primo Inserito (Effettivo)

4 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

8 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

4 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

Descrizione del piano IPD

De-identified individual participant data underlying the results reported in the publication will be shared upon reasonable request. Shared data may include baseline characteristics, group allocation, clinical outcome scores, patient-reported outcome measures, health-related quality-of-life scores, and MRI assessment data.

Periodo di condivisione IPD

Data will be available upon reasonable request after publication, with no predetermined end date.

Criteri di accesso alla condivisione IPD

Qualified researchers may request access by contacting the corresponding author. Requests will be reviewed based on scientific purpose, ethical approval where applicable, and compliance with applicable data protection requirements. Only de-identified data relevant to the approved request will be shared.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi